JPRN-jRCT2080223845招募中2 期
ST-605 uncontrolled open-label phase 2 study in patients with herpes simplex virus keratitis
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1) Patients who are diagnosed as HSV epithelial keratitis (dendritic or geographic keratitis)
- •2) Patients who are 18 years old or more
- •3) Patients who have informed consent
排除标准
- 未提供
研究者
相似试验
未知
2 期
ST-605 phase 2 studyCMV corneal endotheliitisJPRN-jRCT2080223131M's Science Corporation5
已完成
2 期
A clinical study to see the effect of ArtemiC in patients with COVID-19CTRI/2021/02/031520MGC Pharmaceuticals Ltd20
进行中（未招募）
1 期
A clinical study to investigate the efficacy and safety of copanlisib in patients with relapsed or refractory diffuse large B-cell lymphoma.EUCTR2014-004848-36-ITBayer HealthCare AG67
进行中（未招募）
1 期
A clinical study to investigate the efficacy and safety of copanlisib inpatients with relapsed or refractory diffuse large B-cell lymphoma.EUCTR2014-004848-36-BEBayer AG66
进行中（未招募）
1 期
A clinical study to investigate the efficacy and safety of copanlisib inpatients with relapsed or refractory diffuse large B-cell lymphoma.patients with relapsed or refractory diffuse large B cell lymphomaEUCTR2014-004848-36-DKBayer HealthCare AG66